Goldfinch Bio: Goldfinch Bio Announces Publication in Science Advances on the Validation of Human Derived Organoids as a Predictable and Translatable Preclinical Model in Kidney Disease for the Evaluation of Therapeutic Drug Candidates

- Company shares proprietary and scalable approach using human derived organoids for preclinical pharmacodynamic (PD) assessment of drugs targeting podocyte cells - - Recent preliminary data from Phase 2 study of GFB-887 in focal segmental glomerular disease (FSGS) further validate feasibility and value of using transplanted human organoids in preclinical PD studies - CAMBRIDGE, Mass.-(BUSINESS [...]